Se. Strand et M. Strandh, PARAMETERS TO CONSIDER FOR MEASUREMENTS OF ABSORBED DOSES IN-VIVO WITH MINI-THERMOLUMINESCENT DOSIMETERS, Cancer, 73(3), 1994, pp. 985-988
Background. For systemic radiation therapy, i.e., radioimmunotherapy,
there is a demand for direct methods of measuring the absorbed dose in
vivo. One such method is the use of mini-thermoluminescent dosimeters
(TLDs). This paper reports an investigation of the sensitivity of tis
sue implanted mini-TLDs (calcium sulfate:Dy, 0.2 X 0.4 X 5.0 mm). Meth
ods. After being irradiated with cobalt-60, the mini-TLDs were left fo
r as long as 9 days in air, gel, and muscle tissue. Results. There was
an extensive signal loss, which increased with time, except in air. A
fter 9 days in gel or muscle tissue at room temperature, the signal wa
s decreased to one third of its original value. The dosimeters needed
to be kept in constant darkness. There was a strong pH dependence, wit
h a loss of sensitivity of 63% at a pH below 5, which got smaller at h
igher pH values and reached 10% at pH = 10. Conclusions. When using mi
ni-TLDs in vivo, one must calibrate the dosimeters in similar milieus,
unless the position of the dosimeters in tissue after implantation ca
n be monitored for temperature, pH, and liquid flow.